Bridge City Capital’s Utah Medical Products UTMD Stock Holding History

Bridge City Capital’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$493K	Hold	6,654	–	–	0.1%	98
2026 Q2	$459K	Sell	6,654 -637	-9%	-$42.3K	0.1%	103
2026 Q1	$452K	Buy	7,291 +407	+6%	+$25.6K	0.13%	99
2025 Q4	$385K	Buy	6,884 +1,254	+22%	+$72.7K	0.11%	101
2025 Q3	$355K	Buy	5,630 +646	+13%	+$38.2K	0.09%	98
2025 Q2	$284K	Sell	4,984 -127	-2%	-$6.91K	0.08%	104
2025 Q1	$286K	Sell	5,111 -162	-3%	-$9.7K	0.09%	99
2024 Q4	$324K	Buy	5,273 +9	+0.2%	+$582	0.09%	102
2024 Q3	$352K	Hold	5,264	–	–	0.1%	106
2024 Q2	$352K	Buy	5,264 +709	+16%	+$48.3K	0.12%	105
2024 Q1	$324K	Buy	4,555 +1,379	+43%	+$103K	0.12%	104
2023 Q4	$267K	Buy	+3,176	New	+$263K	0.1%	102

Other funds holding UTMD

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $861M AUM 27.19% 1-Year Est. Return

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Bridge City Capital's UTMD Position: Q3 2026 in Review

Bridge City Capital held its Utah Medical Products (UTMD) position steady in Q3 2026 at 6,654 shares worth $493K. The position accounts for 0.1% of the portfolio, ranked #98.

Bridge City Capital first reported a position in UTMD in Q4 2023 and has held it in 12 quarters since. 49 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

Bridge City Capital held 6,654 shares of Utah Medical Products worth $493K as of Q3 2026.
Bridge City Capital left its Utah Medical Products share count unchanged in Q3 2026.
Utah Medical Products made up 0.1% of Bridge City Capital's portfolio in Q3 2026, its #98 holding.
Bridge City Capital first reported a position in Utah Medical Products in Q4 2023 and has held it in 12 quarters since.
49 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on Bridge City Capital's 13F filing for Q3 2026, filed 29 Oct 2026.